Head-to-head
Hims & Hers vs Enhance MD
Compared on both medications across the eight dimensions this database records. They differ on 6 of those eight. Enhance MD is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
Hims & Hers is $697 a month all-in for tirzepatide; Enhance MD is $280. Over twelve months that is $8,364 against $3,360. Value Scores are 27.5 and 57.8 out of 100.
Tirzepatide
Plan pages: Hims & Hers plans · Enhance MD plans
At 10 mg/week, Hims & Hers is $697 a month all-in and Enhance MD is $280 — $417 apart, or $5,004 across a year. Over twelve months the totals are $8,364 (billed monthly) and $3,360 (billed monthly).
Hims & Hers charges a flat $548 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay. The company publishes no price at 5, 7.5, 12.5, 15 mg, so those doses are left blank rather than estimated.
Enhance MD prices tirzepatide by dose: $169 per month at 2.5 mg rising to $280 at 10 mg, a difference of $111 a month between the bottom and top of the ladder. The company publishes no price at 5, 7.5, 12.5, 15 mg, so those doses are left blank rather than estimated.
| Dose | Hims & Hers | Rank | Enhance MD | Rank | Cheaper |
|---|---|---|---|---|---|
| 2.5 mg | $548 | 30/31 | $169 | 2/31 | Enhance MD by $379 |
| 5 mg | — | — | — | — | neither publishes |
| 7.5 mg | — | — | — | — | neither publishes |
| 10 mg | $548 | 25/27 | $280 | 9/27 | Enhance MD by $268 |
| 12.5 mg | — | — | — | — | neither publishes |
| 15 mg | — | — | — | — | neither publishes |
Enhance MD is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 27 programs this database can rank on tirzepatide, Hims & Hers sits 25 of 27 on all-in monthly cost and Enhance MD sits 7. There are 17 other programs priced between them. The field median is $339 and the floor is $169, so Enhance MD is below the median and the other is above it. Hims & Hers is $528 above the cheapest tirzepatide program on record. Enhance MD is $111 above the cheapest tirzepatide program on record.
LillyDirect (Zepbound), the lowest FDA-approved tirzepatide channel here, is $449 a month — Hims & Hers undercuts it by $-248, Enhance MD by $169. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | Hims & Hers | Enhance MD | Cheaper |
|---|---|---|---|
| Month to month | $548 | $280 | Enhance MD by $268 |
| Settled dose | Hims & Hers | Enhance MD | Difference |
|---|---|---|---|
| 2.5 mg | $8,364 | $2,028 | $6,336 apart |
| 10 mg | $8,364 | $3,360 | $5,004 apart |
Hims & Hers publishes no rate for 3-month term, 6-month term, 12-month term; Enhance MD publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $8,364 on Hims & Hers and $3,249 on Enhance MD — $5,115 apart, and a different gap from the $5,004 you would get by multiplying the monthly difference by twelve. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
That calculation is partial: Hims & Hers publishes no price at 2 of the 6 doses and Enhance MD publishes no price at 2 of them, so the maintenance rate stands in for the missing steps rather than a number the company has stated.
Value Scores are 27.5 for Hims & Hers and 57.8 for Enhance MD, against a tirzepatide category floor of $169. Enhance MD leads by 30.3 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| Hims & Hers | 17.0 | 10.5 | 0 | 0 | 27.5 |
| Enhance MD | 42.2 | 10.5 | 0 | 5 | 57.8 |
Semaglutide
Plan pages: Hims & Hers plans · Enhance MD plans
At 2.4 mg/week, Hims & Hers is $602 a month all-in and Enhance MD is $212 — $390 apart, or $4,680 across a year. Over twelve months the totals are $7,224 (billed monthly) and $2,544 (billed monthly).
Hims & Hers charges a flat $453 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay. The company publishes no price at 0.5, 1, 1.7 mg, so those doses are left blank rather than estimated.
Enhance MD charges a flat $212 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
Enhance MD is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Value Scores are 25.5 for Hims & Hers and 58.1 for Enhance MD, against a semaglutide category floor of $129. Enhance MD leads by 32.6 points, driven mostly by price.
Where the two programs differ
All-in monthly
Enhance MD is cheaper month to month — $280 against $697, a gap of $417 every month, or $5,004 across a year if both rates hold.
Cancellation terms
Cancellation differs: Hims & Hers states Cancel anytime, while Enhance MD states Per provider terms. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
Hims & Hers asks for Membership month-to-month ($39 first month); Enhance MD asks for Monthly, with a first-month discount on GLP-1 Core ($112 first month). This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Membership fee
Hims & Hers charges a membership of $149 a month on top of the medication. That is already folded into the all-in figures above — it is broken out here because a membership is a recurring charge that continues even in a month you skip a shipment.
Shipping
Hims & Hers bills shipping separately at $5; the other includes it.
Twelve-month cost
Over twelve months the totals are $8,364 for Hims & Hers and $3,360 for Enhance MD. Enhance MD is lower by $5,004 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Dose policy
Both price by dose, so both advertised figures understate the cost of a titration year. Compare the ladders above rather than the headline rates.
Evidence status
Both figures carry the same evidence status, reported: sourced from dated third-party reporting; first-party capture pending. Neither is stronger than the other on provenance.
What each record says
Hims & Hers Official site
After settling with Novo Nordisk on March 9, 2026 and exiting compounded semaglutide for new patients, Hims & Hers now runs a branded-only GLP-1 service: Wegovy injection $299/month, oral Wegovy $249/month, and Zepbound $399/month, on top of a $149/month membership ($39 first month) plus $5 shipping.
It names its compounding pharmacy — Brand fulfillment (Wegovy, oral Wegovy, Zepbound) + partner pharmacy, recorded as Brand channel — which can be checked against state board licensing and FDA inspection records before you order; commitment terms are Membership month-to-month ($39 first month); cancellation is Cancel anytime; availability is stated as 50 states.
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — Post-settlement pricing reported May–Jun 2026 (Wegovy $299 / oral $249 / Zepbound $399 + $149 membership + $5 shipping); first-party checkout capture pending
Watch: The membership is the number that moves the math: a $299 Wegovy pen becomes ~$453/month all-in. Compare against going to NovoCare or LillyDirect directly.
Enhance MD Official site
Enhance MD bundles GLP-1 medication inside a broader metabolic program including NAD+ coaching, lab testing every six months, and ongoing provider care. The price reflects the full metabolic bundle, not the GLP-1 alone; this makes Enhance MD's figures the least comparable in the database.
It does not publicly name its compounding pharmacy; the record shows Partner 503A pharmacy (not named), so who actually makes the medication cannot be independently verified; commitment terms are Monthly, with a first-month discount on GLP-1 Core ($112 first month); cancellation is Per provider terms; availability is stated as Confirm at intake.
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com, Enhance MD verified 2026-07-14; price reflects metabolic bundle, not GLP-1 alone
Watch: Figures reflect the bundled metabolic program price, not GLP-1 medication alone. Comparing Enhance MD's $212–$322 to medication-only programs overstates the GLP-1 cost while understating the breadth of service included. The $169 microdosing figure is the most medication-proximate but involves a different dosing protocol. Reported — RangeYourself 2026-07-14.
What neither record tells you
Hims & Hers does not publish
- no tirzepatide price at 5, 7.5, 12.5, 15 mg per week
- no published twelve-month tirzepatide rate
- no semaglutide price at 0.5, 1, 1.7 mg per week
- no published twelve-month semaglutide rate
Enhance MD does not publish
- no tirzepatide price at 5, 7.5, 12.5, 15 mg per week
- no published twelve-month tirzepatide rate
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says Confirm at intake
- no specific cancellation or refund terms
Ask Hims & Hers and Enhance MD for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Evidence may be upgraded. Hims & Hers, Enhance MD carry a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Which one suits which reader
On the lowest standing monthly rate for tirzepatide, Enhance MD Official site wins this matchup. If you want to be able to pause without still paying, enhance md carries no membership.
Both figures should be checked at the provider's own checkout before you pay. Hims & Hers's tirzepatide price is reported as of 2026-08-11; Enhance MD's is reported as of 2026-07-14.
Questions
Is Hims & Hers or Enhance MD cheaper for tirzepatide?
Enhance MD is cheaper on all-in monthly cost at 10 mg/week: $280 against $697, a difference of $417 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of Hims & Hers versus Enhance MD?
Hims & Hers works out to $8,364 across twelve months and Enhance MD to $3,360, on the plan terms each publishes.
Does Hims & Hers or Enhance MD raise the price as the dose goes up?
Hims & Hers: yes, it prices by dose. Enhance MD: yes, it prices by dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do Hims & Hers and Enhance MD differ?
6 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of Hims & Hers and Enhance MD names its pharmacy?
Hims & Hers does — Brand fulfillment (Wegovy, oral Wegovy, Zepbound) + partner pharmacy. Enhance MD does not, recording only Partner 503A pharmacy (not named), so who makes its medication cannot be independently verified.
How well evidenced are the Hims & Hers and Enhance MD prices?
Hims & Hers's tirzepatide figure is reported — sourced from dated third-party reporting; first-party capture pending — captured 2026-08-11. Enhance MD's is reported, captured 2026-07-14. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Which is cheaper for semaglutide?
Enhance MD, at $212 a month all-in against $602 at 2.4 mg/week. The two programs do not necessarily lead on both medications.
Official sources: Hims & Hers official site · Enhance MD official site. Compounded tirzepatide and semaglutide are not FDA-approved products.